Tiếp theo

Tự chạy

Dr. Yasmin Thanavala on targeted therapy for liver cancer

2 Lượt xem • 06/28/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy